# Inogen Inc (INGN) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Inogen Inc's 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/INGN/mda/fy2025/): filed 2026-02-27; accession 0001193125-26-082630 (https://www.sec.gov/Archives/edgar/data/1294133/000119312526082630/ingn-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/INGN/mda/fy2024/): filed 2025-02-28; accession 0000950170-25-029993 (https://www.sec.gov/Archives/edgar/data/1294133/000095017025029993/ingn-20241231.htm)
- [FY 2023 MD&A](/company/INGN/mda/fy2023/): filed 2024-03-01; accession 0000950170-24-023820 (https://www.sec.gov/Archives/edgar/data/1294133/000095017024023820/ingn-20231231.htm)
- [FY 2022 MD&A](/company/INGN/mda/fy2022/): filed 2023-02-24; accession 0000950170-23-004370 (https://www.sec.gov/Archives/edgar/data/1294133/000095017023004370/ingn-20221231.htm)
- [FY 2021 MD&A](/company/INGN/mda/fy2021/): filed 2022-02-24; accession 0001564590-22-006703 (https://www.sec.gov/Archives/edgar/data/1294133/000156459022006703/ingn-10k_20211231.htm)

Back to /company/INGN/